Engineered trimeric ACE2 binds viral spike protein and locks it in "Three-up" conformation to potently inhibit SARS-CoV-2 infection

Cell Res. 2021 Jan;31(1):98-100. doi: 10.1038/s41422-020-00438-w. Epub 2020 Nov 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / chemistry*
  • Angiotensin-Converting Enzyme 2 / pharmacology
  • COVID-19 / metabolism
  • COVID-19 Drug Treatment*
  • Humans
  • Mutation, Missense*
  • Protein Binding
  • Protein Engineering
  • Protein Multimerization*
  • SARS-CoV-2 / chemistry*
  • SARS-CoV-2 / metabolism

Substances

  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2